According to Tabula Rasa HealthCare 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -2.72727. At the end of 2022 the company had a P/E ratio of -0.8128.
Year | P/E ratio | Change |
---|---|---|
2022 | -0.8128 | -81.58% |
2021 | -4.41 | -62% |
2020 | -11.6 | -62.32% |
2019 | -30.8 | 20.32% |
2018 | -25.6 | -167.55% |
2017 | 37.9 | -142.42% |
2016 | -89.4 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.